Live feed
Filing
SC 13G/A
SC 13G/A0001213900-21-030186·Corbus Pharmaceuticals Holdings, Inc.
Schedule 13G ownership disclosure
Corbus Pharmaceuticals Holdings, Inc.
Security class unavailable · CUSIP: 21833P103
Event date: 2021-05-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 14,240,357
- Percent of class
- 11.3900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-21-030186
- Form type
- SC 13G/A
- Filer
- Corbus Pharmaceuticals Holdings, Inc.
- CIK
- CIK 1595097
- Filed
- Jun 01, 2021
- Reporting period
- May 28, 2021
- Description
- Schedule 13G beneficial ownership